We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMEA Guidance Addresses Environmental Risks of GMO-Based Gene Therapies
EMEA Guidance Addresses Environmental Risks of GMO-Based Gene Therapies
April 12, 2007
The European Medicines Agency (EMEA) has published a draft guideline describing scientific principles and methodology for conducting environmental risk assessments (ERAs) of gene therapy medicinal products that contain genetically modified organisms, or GMOs.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor